Joseph Herbert

Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomised, phase 3 study

Ludwig Kappos, Amit Bar‐Or, Bruce Cree et al. · The Lancet · 2018 · 896 citations

Neurological Disorder, Clinical Neurology, Clinical Trials +9

Dehydroepiandrosterone (DHEA) and DHEA-sulfate (DHEAS) protect hippocampal neurons against excitatory amino acid-induced neurotoxicity

V. G. Kimonides, Nikan H. Khatibi, Clive N. Svendsen et al. · Proceedings of the National Academy of Sciences · 1998 · 443 citations

Natural History of Multiple Sclerosis Symptoms

Ilya Kister, Tamar Bacon, Eric Chamot et al. · International Journal of MS Care · 2013 · 439 citations · Full text

Disease Progression, Neurological Disorder, Disability +18

Improvement in Mood and Fatigue after Dehydroepiandrosterone Replacement in Addison’s Disease in a Randomized, Double Blind Trial

Penelope J. Hunt, Eleanor Gurnell, Felicia A. Huppert et al. · The Journal of Clinical Endocrinology & Metabolism · 2000 · 359 citations

Transthyretin

Joseph Herbert, Josiah N. Wilcox, Kim-Thu C. Pham et al. · Neurology · 1986 · 326 citations

Plasma Transthyretin, Genetics, Plasma Transport +8